Biomedical subjects
Publications and source records attributed to E Ortega.
A modification to the radiochemical assay method to measure testosterone in serum, that renders unnecessary the extraction of testosterone from a serum sample is described. The serum is heated at 60 degrees C for 1 hour, thereby testosterone binding proteins are destroyed, then radioimmunoassay follows as usual.
A modification to the radiochemical assay method to measure cortisol in serum, that renders unnecessary the extraction of cortisol from a serum sample is described. The serum is heated at 60 degrees C for 3 hours, thereby transcortine is destroyed, then competition binding assay follows as usual.
The efficiency of L-dopa and exercise tests have been compared to diagnose the lack of human growth hormone. Both tests gave similar results. The exercise test is recommended as a screening method in large populations to discard growth inhibition due to HGH deficiency, because of its easy, quick and painless application to patients.
The serum levels of testosterone, follicle-stimulating hormone (FSH) and luteinizing hormone (LH) have been measured in healthy man of different ages to stablish their normal values in the population of Granada. The serum levels of testosterone, FSH and LH have been compared to each other in each age group. No clear relation between these hormones was found at any age.
In earlier safety studies, naproxen, 600 mg three times daily, was administered to healthy subject without significant adverse effects. Another study demonstrated that single doses of 500 to 900 mg resulted in accelerated renal clearance and a nonlinear naproxen plasma level response after the higher doses. Our report describes the pharmacokinetics of naproxen when administered in single doses of 1, 2, 3, or 4 gm (up to eight times the clinically effective dose in rheumatoid arthritis) to healthy subjects. An increase in urinary excretion rate and continuation of the previously documented nonlinear plasma level response were observed. There were no signs that capacity to conjugate or to excrete the drug was exceeded. There were no adverse effects.
The effects of cloprednol and other corticosteroids on hypothalamic-pituitary-adrenal (HPA) function were studied in healthy subjects after administration of a single oral dose of corticosteroid at 6 a.m. or 6 p.m., and after daily 6 a.m. administration of corticosteroids at various doses for seven days. The degree of HPA suppression was assessed by metyrapone tests (METP), insulin hypoglycaemia tests (IHT) and 6 a.m. fasting plasma cortisol concentrations. Regardless of the corticosteroid tested, 6 p.m. dosing was at least four-fold more suppressive of METP response than 6 a.m. administration. At therapeutically equivalent doses, single doses of triamcinolone and dexamethasone were more suppressive of HPA-axis function than cloprednol, hydrocortisone or prednisolone, After 6 a.m. administration for seven days, 12-5 mg of cloprednol did not impair the cortisol response to IHT or interfere with the METP response. The clinically equivalent dose of prednisolone (25 mg) resulted in slightly greater HPA-axis suppression. All doses of dexamethasone (0-5, 3-75 and 6-0 mg) and of betamethasome (2-0, 4-0 and 6-5 mg) were more suppressive of HPA-axis function than either cloprednol or prednisolone. These results suggest that at equipotent anti-inflammatory doses, cloprednol is slightly less suppressive of HPA-axis function than prednisolone, and both cloprednol and prednisolone are much less suppressive than dexamethasone or betamethasone.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.